At a glance
ClinicalIndex Comparison RecordN/ACompleted· 965 enrolled
Drug / intervention
White Light +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multi-center, International Study to Compare Use of Narrow Band Imaging (NBI) Versus White Light(WL) During Transurethral Resection of Bladder Tumors (TURB) to Asses Recurrence of Bladder Cancer in Terms of Safety and Efficacy
Clinical Research Office of the Endourological Society·interventional·Posted Aug 12, 2010·Updated Apr 25, 2018
In Brief
A clinical study evaluating White Light and Narrow Band Imaging for Bladder Cancer. Completed, enrolled 965 participants.
Detailed Summary
The purpose of this study is to compare the recurrence rate at 1 year following Narrow Band Imaging and trans-urethral resection of bladder tumor with White Light and TURB in patients with non-muscle invasive bladder cancer.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBladder Cancer
Countries--
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartAug 2010
First PostedAug 2010
Primary CompletionNov 2013
TodayJul 2026
First PostedAug 12, 2010
Enrollment StartAug 1, 2010
Primary CompletionNov 1, 2013
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 15.9 years ago
Interventions
White Lightdevice
White Light Cystoscopy
Narrow Band Imagingdevice
Narrow Band Imaging